|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Plasmodium Vivax Malaria | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Malaria | |||||
| Malaria, Vivax | |||||
| 3 | More general conditions related to this trial | ||||
| Coccidiosis | |||||
| Parasitic Diseases | |||||
| Protozoan Infections | |||||
| 4 | Sponsors listed in this trial | ||||
| National Institute of Allergy and Infectious Diseases (NIAID) | |||||